John Franklin  Fowler net worth and biography

John Fowler Biography and Net Worth

Co-Founder of Kezar Life Sciences
John Fowler is our Co-Founder, Chief Executive Officer, and a member of the board of directors, bringing over 20 years of executive leadership experience to the company. Prior to co-founding Kezar, between 2009 and 2014 John co-founded and was CEO of HealthCPA, a provider of patient advocacy and insurance navigation services. From 2003 to 2008 John served as CEO of specialty shipping company Aero Logistics, which he and a business partner acquired using a specialty investment company they founded in 2001. Prior to his CEO roles, John also worked with Idealab Silicon Valley and as a management consultant with William Kent International, advising clients on international acquisition opportunities and market entry strategies. He began his career on Capitol Hill and later in the Clinton Administration, as a Congressional Affairs Specialist for the U.S. Trade Representative. John received both his A.B. in International Relations and his M.B.A. from Stanford University, where during his undergraduate years he competed on the varsity track team.

How old is John Franklin Fowler?

Mr. Fowler is currently 52 years old. There are 2 older executives and no younger executives at Kezar Life Sciences. The oldest executive at Kezar Life Sciences is Mr. Marc L. Belsky, CFO & Secretary, who is 69 years old. Learn More on John Franklin Fowler's age.

How do I contact John Franklin Fowler?

The corporate mailing address for Mr. Fowler and other Kezar Life Sciences executives is 4000 SHORELINE COURT SUITE 300, SOUTH SAN FRANCISCO CA, 94080. Kezar Life Sciences can also be reached via phone at (650) 822-5600 and via email at [email protected]. Learn More on John Franklin Fowler's contact information.

Has John Franklin Fowler been buying or selling shares of Kezar Life Sciences?

John Franklin Fowler has not been actively trading shares of Kezar Life Sciences during the last quarter. Learn More on John Franklin Fowler's trading history.

Who are Kezar Life Sciences' active insiders?

Kezar Life Sciences' insider roster includes Marc Belsky (CFO & Sec. ), John Fowler (Co-Founder), and Michael Kauffman (Director). Learn More on Kezar Life Sciences' active insiders.

Are insiders buying or selling shares of Kezar Life Sciences?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 668 shares worth more than $3,874.40. The most recent insider tranaction occured on July, 2nd when insider Mark C Schiller sold 668 shares worth more than $3,874.40. Insiders at Kezar Life Sciences own 9.3% of the company. Learn More about insider trades at Kezar Life Sciences.

Information on this page was last updated on 7/2/2024.

John Franklin Fowler Insider Trading History at Kezar Life Sciences

See Full Table

John Franklin Fowler Buying and Selling Activity at Kezar Life Sciences

This chart shows Mr. John Franklin Fowler's buying and selling at Kezar Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kezar Life Sciences Company Overview

Kezar Life Sciences logo
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $7.49
Low: $7.45
High: $7.58

50 Day Range

MA: $7.31
Low: $5.29
High: $8.95

2 Week Range

Now: $7.49
Low: $5.20
High: $11.35

Volume

106,671 shs

Average Volume

67,698 shs

Market Capitalization

$54.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22